These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10455521)

  • 41. In vitro effects of tibolone and its metabolites on human vascular coronary cells.
    Seeger H; Kloosterboer HJ; Studen M; Wallwiener D; Mueck AO
    Maturitas; 2007 Sep; 58(1):42-9. PubMed ID: 17572028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis.
    Azari BM; Marmur JD; Salifu MO; Cavusoglu E; Ehrlich YH; Kornecki E; Babinska A
    Atherosclerosis; 2010 Sep; 212(1):197-205. PubMed ID: 20627246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F.
    Kim MJ; Park KG; Lee KM; Kim HS; Kim SY; Kim CS; Lee SL; Chang YC; Park JY; Lee KU; Lee IK
    Hypertension; 2005 Apr; 45(4):552-6. PubMed ID: 15723965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males.
    Dai-Do D; Espinosa E; Liu G; Rabelink TJ; Julmy F; Yang Z; Mahler F; Lüscher TF
    Cardiovasc Res; 1996 Nov; 32(5):980-5. PubMed ID: 8944830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proliferation of smooth muscle cells in acute allograft vascular rejection.
    Amano J; Ishiyama S; Nishikawa T; Tanaka H; Nagai R; Marumo F; Hiroe M
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):19-25. PubMed ID: 9011689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of dihematoporphyrin derivatives on cultivated human smooth muscle cells from normal and atherosclerotic vascular segments-- Overview of results and implications for photodynamic therapy].
    Dartsch PC; Betz E; Ischinger T
    Z Kardiol; 1991 Jan; 80(1):6-14. PubMed ID: 1827935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matters of the heart: Cellular sex differences.
    Walker CJ; Schroeder ME; Aguado BA; Anseth KS; Leinwand LA
    J Mol Cell Cardiol; 2021 Nov; 160():42-55. PubMed ID: 34166708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in Transforming Growth Factor-β1/BMP7 Signaling and Venous Fibrosis Contribute to Female Sex Differences in Arteriovenous Fistulas.
    Cai C; Kilari S; Singh AK; Zhao C; Simeon ML; Misra A; Li Y; Misra S
    J Am Heart Assoc; 2020 Aug; 9(16):e017420. PubMed ID: 32757791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments.
    Çubuk C; Can FE; Peña-Chilet M; Dopazo J
    Cells; 2020 Jun; 9(7):. PubMed ID: 32610626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults.
    Panwar B; Judd SE; Warnock DG; McClellan WM; Booth JN; Muntner P; Gutiérrez OM
    Stroke; 2016 Aug; 47(8):2017-24. PubMed ID: 27382006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reporting of sex as a variable in cardiovascular studies using cultured cells.
    Taylor KE; Vallejo-Giraldo C; Schaible NS; Zakeri R; Miller VM
    Biol Sex Differ; 2011 Nov; 2():11. PubMed ID: 22060014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status.
    Hogg ME; Varu VN; Vavra AK; Popowich DA; Banerjee MN; Martinez J; Jiang Q; Saavedra JE; Keefer LK; Kibbe MR
    Free Radic Biol Med; 2011 May; 50(9):1065-74. PubMed ID: 21256959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone therapy is associated with preserved smooth muscle structure and dilation in the arterial vasculature of the leg in older women.
    Parker BA; Smithmyer SL; Proctor DN
    Maturitas; 2008 Jan; 59(1):46-54. PubMed ID: 18068915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gender differences in the effect of genistein on vascular smooth muscle cells: a possible cardioprotective effect?
    Vincent A; Ruan M; Fitzpatrick LA
    J Gend Specif Med; 2001; 4(1):28-34. PubMed ID: 11324237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender-related differences in proliferative responses of vascular smooth muscle cells to endothelin-1.
    Antoniucci D; Miller VM; Sieck GC; Fitzpatrick LA
    Endothelium; 2001; 8(2):137-45. PubMed ID: 11572475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The vascular protective effects of estrogen.
    Farhat MY; Lavigne MC; Ramwell PW
    FASEB J; 1996 Apr; 10(5):615-24. PubMed ID: 8621060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender-related differences in vascular smooth muscle cell proliferation: implications for prevention of atherosclerosis.
    Fitzpatrick LA; Ruan M; Anderson J; Moraghan T; Miller V
    Lupus; 1999; 8(5):397-401. PubMed ID: 10455521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential response in cell proliferation to beta estradiol in coronary arterial vascular smooth muscle cells obtained from mature female versus male animals.
    Moraghan T; Antoniucci DM; Grenert JP; Sieck GC; Johnson C; Miller VM; Fitzpatrick LA
    Endocrinology; 1996 Nov; 137(11):5174-7. PubMed ID: 8895395
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.